The 3rd CRISPR MEDiCiNE Conference (CRISPRMED26) brings together the global CRISPR community in Copenhagen on 14–16 April 2026.

As the world’s largest international event focused on CRISPR medicine, the conference highlights cutting‑edge progress in genome editing, delivery technologies, functional genomics, regulatory insights, and clinical translation. For leaders advancing gene therapies, vaccines, and next‑generation genetic medicines, CRISPRMED26 offers unparalleled access.  The program features world‑class speakers, specialised workshops, dynamic poster sessions, and sessions dedicated to CMC, pre‑clinical and clinical pathways, and EU regulatory requirements—core considerations for organisations working toward scalable, compliant therapeutic development.

Touchlight will be on site to discuss how mbDNA™, our enzymatically produced, cell‑free DNA vector, enables faster, safer, and more flexible development of CRISPR‑enabled therapies.

Interested in next‑generation DNA manufacturing? Request a meeting with a Touchlight expert today.

Touchlight Attendees